NANOVIRICIDES, INC. Accrued Liabilities, Current
NANOVIRICIDES, INC. (NNVC) had Accrued Liabilities, Current of $25.85 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-05-15
- 2026-03-31: Accrued Liabilities, Current $25.85K.
- 2025-12-31: Accrued Liabilities, Current $48.38K.
- 2025-09-30: Accrued Liabilities, Current $26.30K.
- 2025-06-30: Accrued Liabilities, Current $25.97K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-03-31 | $25.85K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $48.38K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $26.30K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $25.97K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $32.62K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $65.42K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $283.29K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $262.47K 10-K · filed 2025-09-29 |
| 2024-03-31 | $258.80K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $180.37K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $339.62K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $143.76K 10-K · filed 2024-09-27 |
| 2023-03-31 | $42.17K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $51.88K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $23.71K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $45.69K 10-K · filed 2023-10-13 |
| 2022-03-31 | $25.25K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $24.16K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $24.07K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $24.29K 10-K · filed 2022-10-13 |
| 2021-03-31 | $24.23K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $25.26K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $62.30K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $69.24K 10-K · filed 2021-10-12 |
| 2020-03-31 | $43.56K 10-Q · filed 2020-06-22 |
| 2019-12-31 | $52.63K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $61.26K 10-Q · filed 2019-11-15 |
| 2019-06-30 | $68.87K 10-K · filed 2020-10-13 |
| 2019-03-31 | $107.47K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $139.05K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $231.18K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $253.05K 10-K · filed 2019-08-23 |
| 2018-03-31 | $406.80K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $25.75K 10-Q · filed 2018-02-20 |
| 2017-09-30 | $34.19K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $34.00K 10-K · filed 2018-10-12 |
| 2017-03-31 | $52.27K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $51.59K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $35.65K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $35.60K 10-K · filed 2017-09-28 |
| 2016-03-31 | $78.37K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $12.60K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $19.59K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $28.52K 10-K · filed 2016-09-16 |
| 2015-03-31 | $125.05K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $161.78K 10-Q · filed 2015-02-25 |
| 2014-09-30 | $265.46K 10-Q/A · filed 2015-02-23 |
| 2014-06-30 | $91.84K 10-K · filed 2015-09-14 |
| 2014-03-31 | $207.10K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $224.89K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $319.61K 10-Q/A · filed 2015-02-23 |
| 2013-06-30 | $204.36K 10-K · filed 2015-02-23 |
| 2013-03-31 | $147.25K 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $71.49K 10-Q/A · filed 2013-02-22 |
| 2012-09-30 | $98.26K 10-Q · filed 2012-11-19 |
| 2012-06-30 | $96.88K 10-K/A · filed 2013-10-08 |
| 2012-03-31 | $50.99K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $48.29K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $93.92K 10-Q/A · filed 2011-12-12 |
| 2011-06-30 | $27.17K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |